Costunolide CAS: 553-21-9

CAS NO: 553-21-9
Costunolide
Chemical Name: Costunolide
Molecular Formula: C15H20O2
Formula Weight: 232.32
CAS No.: 553-21-9
Description Review
Description

Costunolide is a natural sesquiterpene lactone derived from various plants, including Saussurea lappa and Laurus nobilis. It has gained attention for its potential therapeutic benefits in various diseases, including inflammation, cancer, and autoimmune disorders. Costunolide targets several signaling pathways involved in these diseases, making it a promising candidate for the development of novel therapeutics.

Chemical name:

(1aR,5aS,8aS,9R)-9-[(E)-3-ethylidene-4-methylpent-4-enoyl]oxy-1a,2,5,5a,6,7,8,8a-octahydro-1H-naphthalen-2-yl acetate

Molecular formula:

C15H20O3

Formula weight:

248.32 g/mol

CAS No:

553-21-9

Top ten keywords from Google and Synonyms:

  1. Costunolide
  2. Sesquiterpene lactone
  3. Inflammation
  4. Cancer
  5. Autoimmune disorders
  6. Signaling pathways
  7. NF-kB
  8. MAPKs
  9. Apoptosis
  10. Chemotherapy

Health benefits of this product:

Costunolide has shown potential health benefits in the treatment of various diseases, including inflammation, cancer, and autoimmune disorders. Studies have shown that costunolide can inhibit the production of pro-inflammatory cytokines and chemokines, reduce oxidative stress, and induce apoptosis in cancer cells. Additionally, costunolide has been found to have immunomodulatory effects, regulating the immune response in autoimmune disorders.

Potential effects:

Costunolide has several potential effects on the body. One of the primary mechanisms is through the inhibition of several signaling pathways involved in inflammation, oxidative stress, and cancer cell proliferation, including NF-kB and MAPKs. Costunolide has also been found to induce apoptotic cell death in cancer cells, as well as inhibit angiogenesis and metastasis. Additionally, costunolide has been found to have immunomodulatory effects, regulating the immune response in autoimmune disorders.

Product mechanism:

Costunolide works by targeting several signaling pathways involved in inflammation, oxidative stress, and cancer cell proliferation. One of the primary mechanisms is through the inhibition of NF-kB and MAPKs, which play key roles in cellular responses to stress and inflammation. By inhibiting these pathways, costunolide can reduce oxidative stress and inflammation. Additionally, costunolide has been found to induce apoptotic cell death in cancer cells, inhibit angiogenesis and metastasis, and regulate the immune response in autoimmune disorders.

Safety:

Costunolide has been found to be generally safe in preclinical studies. However, further research is needed to determine the safety and efficacy of costunolide in humans.

Side effects:

Currently, there is limited information available regarding the potential side effects of costunolide. Some studies have reported mild adverse events such as nausea and gastrointestinal disturbances. Further research is needed to determine the full extent of the drug's side effects.

Dosing information:

There are currently no established guidelines for the dosing of costunolide in humans. Doses used in preclinical studies have ranged from 2.5 to 100 mg/kg. Further research is needed to determine the optimal dosing regimen for costunolide in humans.

Conclusion:

Costunolide is a natural compound with potential therapeutic benefits in the treatment of various diseases, including inflammation, cancer, and autoimmune disorders. The drug has been shown to target several signaling pathways involved in these diseases, making it a promising candidate for the development of novel therapeutics. However, its safety and efficacy in humans need to be further studied. Overall, costunolide shows great promise as a targeted therapy for various diseases, and may provide valuable insights into the development of future treatments for inflammatory, neoplastic, and autoimmune disorders

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code